drugset / Trial / NCT01009567

Compare the Efficacy of Human Albumin With Cabergoline to Prevent Ovarian Hyper Stimulation in Assisted Reproductive Technology (ART) Program

NCT01009567

Phase 1/2 Completed 10 enrolled Royan Institute
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to investigate the efficacy and safety of cabergoline in prevention of ovarian hyperstimulation syndrome versus albumin in ART program.

Timeline

Start
2009-06
Primary completion
2013-06
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 20 g Intravenous
Subject Cabergoline Small molecule 0.5 mg Oral